Safety and efficacy of camrelizumab combined with radiotherapy as neoadjuvant therapy for locally advanced esophageal squamous cell carcinoma: a prospective single-arm phase II clinical trial protocol

Peer Review reports

Original Submission
16 Apr 2023	Submitted	Original manuscript
22 May 2023	Reviewed	Reviewer Report - Cynthia Basu
3 Jul 2023	Reviewed	Reviewer Report - Research Square Reviewer 1
14 Jul 2023	Author responded	Author comments - Maohui Chen
Resubmission - Version 2
14 Jul 2023	Submitted	Manuscript version 2
Publishing
21 Jul 2023	Editorially accepted
25 Aug 2023	Article published	10.1186/s13063-023-07534-3

Back to article page